Hendrik Peter Scholl
Chief Medical Officer at Belite Bio, Inc (BLTE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 5SEC | BLTEBelite Bio, Inc | Sell Plan | 20014,800 held (−1%) | $163.62 | $33K | -5.6% |
| Oct 5SEC | BLTEBelite Bio, Inc | Sell Plan | 2414,776 held (−0%) | $164.64 | $4K | -6.2% |
| Oct 5SEC | BLTEBelite Bio, Inc | Sell Plan | 12014,656 held (−1%) | $165.49 | $20K | -6.6% |
| Oct 5SEC | BLTEBelite Bio, Inc | Sell Plan | 5014,606 held (−0%) | $166.44 | $8K | -7.2% |
| Oct 5SEC | BLTEBelite Bio, Inc | Sell Plan | 7814,528 held (−1%) | $167.59 | $13K | -7.8% |
| Oct 5SEC | BLTEBelite Bio, Inc | Sell Plan | 1214,516 held (−0%) | $168.21 | $2K | -8.2% |
| Oct 5SEC | BLTEBelite Bio, Inc | Sell Plan | 1414,502 held (−0%) | $169.36 | $2K | -8.8% |
| Oct 5SEC | BLTEBelite Bio, Inc | Sell Plan | 214,500 held (−0%) | $170.02 | $340 | -9.1% |
| Jun 22SEC | BLTEBelite Bio, Inc | Sell | 9624,904 held (−0%) | $143.90 | $14K | +7.4% |
| Jun 22SEC | BLTEBelite Bio, Inc | Sell | 3,74821,156 held (−15%) | $144.66 | $542K | +6.8% |
| Jun 22SEC | BLTEBelite Bio, Inc | Sell | 4,86116,295 held (−23%) | $145.43 | $707K | +6.2% |
| Jun 22SEC | BLTEBelite Bio, Inc | Sell | 1,19915,096 held (−7%) | $146.24 | $175K | +5.6% |
| Jun 22SEC | BLTEBelite Bio, Inc | Sell | 9615,000 held (−1%) | $147.11 | $14K | +5.0% |
| Jun 17SEC | BLTEBelite Bio, Inc | Sell | 2,05432,946 held (−6%) | $137.61 | $283K | +12.3% |
| Jun 17SEC | BLTEBelite Bio, Inc | Sell | 78432,162 held (−2%) | $138.18 | $108K | +11.8% |
| Jun 17SEC | BLTEBelite Bio, Inc | Sell | 3,14029,022 held (−10%) | $139.57 | $438K | +10.7% |
| Jun 17SEC | BLTEBelite Bio, Inc | Sell | 54028,482 held (−2%) | $140.58 | $76K | +9.9% |
| Jun 17SEC | BLTEBelite Bio, Inc | Sell | 10028,382 held (−0%) | $141.83 | $14K | +8.9% |
| Jun 17SEC | BLTEBelite Bio, Inc | Sell | 45027,932 held (−2%) | $142.20 | $64K | +8.6% |
| Jun 17SEC | BLTEBelite Bio, Inc | Sell | 1,89726,035 held (−7%) | $143.55 | $272K | +7.6% |
| Jun 17SEC | BLTEBelite Bio, Inc | Sell | 1,03525,000 held (−4%) | $145.02 | $150K | +6.5% |
- Sell
Chief Medical Officer Hendrik Peter Scholl sold $33K of BLTE at $163.62 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Hendrik Peter Scholl sold $4K of BLTE at $164.64 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Hendrik Peter Scholl sold $20K of BLTE at $165.49 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Hendrik Peter Scholl sold $8K of BLTE at $166.44 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Hendrik Peter Scholl sold $13K of BLTE at $167.59 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Hendrik Peter Scholl sold $2K of BLTE at $168.21 — pre-scheduled 10b5-1 plan sale.